Combining fragmentation profiles, clinical risk factors, CEA levels, and machine learning approaches, followed by CT imaging, 91% of patients with stage I/II lung cancer were detected with 80% specificity [165]. The gene discussed is CEACAM5; the disease is lung cancer.